Publication | Open Access

In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis

Amyotrophic Lateral SclerosisMolecular NeuroscienceDisease ProgressionNeurochemical BiomarkersIn-vivo Genetic AblationNeurologyNeuroscienceNeurodegenerationMolecular NeurobiologyMedicineSocial Sciences